about
CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host diseaseBone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes.Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults.Role for macrophage migration inhibitory factor in asthma.Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitisMacrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathyDual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization.The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor.Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis.Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy.Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain.Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats.Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathyMacrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritisHigh-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's diseaseHepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathyMacrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitisElevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetesHigh macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasisIdentification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharideElevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosisHigh expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid jointsIncreased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areataVitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy
P50
Q24644566-6FDAA697-E5D6-4486-B22D-2E73524824C8Q27319925-F3871316-185A-4BDD-B1C6-1DF722528428Q33623765-0C2BC045-4C91-429D-8964-8AE5121F2A06Q34063699-CDC0F596-A58C-452C-AD9F-9411DD87B9DAQ35312819-63E4E5E7-4595-4D02-90CE-53EBDE3411B0Q35314709-5F498FC0-6CA4-4C19-97F7-EEAFC24A22B5Q35585133-18F0065A-F4FA-4D64-A16A-09E0DD5C798EQ36979727-229DAFDA-2B12-4A48-97EA-C367DC0B1FC3Q39849398-E5273C04-493E-4040-B045-3174ED75B3FCQ41380774-21E1B0BC-EF7B-44BD-92E8-F3E79833C2F7Q41436644-971173BA-4B32-4A8E-A70E-6B06B957309FQ43820960-D74E9A0E-A171-44ED-894B-128F34328742Q44025837-B09262E4-29BF-4ED7-A93C-2C31011A4536Q44054036-BC3BD07A-6C2D-46C4-9962-7614C2BC2756Q45166067-2EC20471-0116-4324-A57E-507DE985BE4BQ45879223-D92BE120-4182-4F5A-8AD1-5A8717B64450Q46419634-B3336E11-511A-40F7-800C-C2D1100C36FBQ47837449-C7FE4CD9-083E-4BBA-98ED-6934481FF5EAQ48215647-5864DAB5-89CA-495B-BBA3-278CF6CDFB9AQ73305101-A50DB117-4EED-4A19-9EBE-64286AC66932Q73316815-64FC76EB-D794-455A-81B4-17D83DB47405Q73545857-C0718A4C-F7DC-430B-9AD4-13017648C6D5Q73871014-153DDF01-0274-47B3-ABB1-D4CEDF2FC609Q73876864-8FB7B1C0-2208-4C9F-A5CC-BBE339CF56BBQ73928800-CB24C5FA-644A-4E8B-A214-B4294CE679C5Q74025058-FFD87C8C-D7CD-493E-91AC-D51DF0CAE647Q74518854-A3041534-1CE3-4C09-A992-CC122DE26706Q74582730-5E718E25-E73D-44CB-AFC6-5058DBD82731Q74629261-B2FA6550-D193-4A85-87E6-1A2C53AF5E81Q77717316-70E5078F-4AFC-4308-93D2-D0EEF124DE36Q78579831-37D00FB6-297F-4A38-97E9-2E06B5258F05
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yuka Mizue
@ast
Yuka Mizue
@en
Yuka Mizue
@es
Yuka Mizue
@nl
type
label
Yuka Mizue
@ast
Yuka Mizue
@en
Yuka Mizue
@es
Yuka Mizue
@nl
prefLabel
Yuka Mizue
@ast
Yuka Mizue
@en
Yuka Mizue
@es
Yuka Mizue
@nl
P106
P1153
6602940705
P31
P496
0000-0002-2208-0772